Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Regeneron Pharmaceuticals (REGN) Q3 2022 Earnings
REGN
-1.66%
3
Aug
Confirmed
Q4 2021
Q1 2022
Q2 2022
Q3 2022
8.57
12.82
17.07
21.32
Details
Expected EPS
8.57
Actual EPS
9.77
Surprise EPS
1.2
Surprise Percent
+14%
Description
Regeneron Pharmaceuticals (REGN) has reported earnings of 9.77 per share for Q3 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login